期刊文献+

不同淋巴细胞输注对非清髓小鼠异基因骨髓干细胞移植的影响 被引量:2

Research on mouse treated with allo-BMT plus DLI post nonlethal preconditioning
下载PDF
导出
摘要 目的:建立小鼠非清髓异基因骨髓干细胞移植模型,探讨不同的供者淋巴细胞输注(donor lympho-cytes infusion DLI)对移植效果的影响及其机制。方法:受者鼠为Balb/c小鼠,供者鼠为C57b l/6小鼠,依据不同DLI将受者鼠随机分为A、B、C、D和E 5组,每组5只。5组均给予预处理,A组预处理后于移植d1给予供者小鼠全脾细胞1.0×107个;B组分别于移植后d1、7、14给予供者小鼠全脾细胞0.3×107个;C组于移植后d1、7给予去除CD8+细胞供者鼠脾细胞0.5×107个;D组于移植后d1、7给予供者鼠全脾细胞0.5×107个,E组为对照组,只作预处理,不作干细胞移植及DLI处理。观察各组嵌合状态、造血恢复情况、移植物抗宿主反应(graft versus host d isease GVHD)。结果:未移植组嵌合率为22.33%,为非特异性粘着,移植组小鼠嵌合率均在80%以上,与未移植组相比差别显著;除C组一只小鼠死亡外其余均存活,并于移植后20天自行恢复造血功能,但C组白细胞计数小于2.0×109/L持续到d16,恢复明显比其余组慢,GVHD评分A、B组间无明显统计学差异(P=0.173),C、D组间相比有统计学差异(P=0.033)。结论:建立非清髓小鼠异基因骨髓干细胞移植模型条件适宜,且去除CD8+细胞的DLI移植后GVHD比未去除组要严重,移植效果相对较差。 Objective:Establish a mouse model of allo-BMT with nonlethal preconditioning, observe the effect and research mechanism of allo -BMT with different DLI . Methods: Recipient mouse was Balb/c and donor was C57bl/6. Twenty five recipient mice were divided into A,B,C,D and E group according to different DLI randomly. All the mice were preconditioned, the mice in group A were treated with 1.0×10^7 donor mice's whole spleen cells on day+1 after transplantation ; The mice in group B were treated with 0.3×10^7 donor mice's whole spleen cells on day+1, +7, +14 after transplantation; The mice in Group C were treated with 0.5×10^7 donor mice's CD8-spleen cells on day+1, +7 after transplantation; The mice in group D were treated with 0.5×10^7 donor mice's whole spleen cells on day+1, +7 ; Group E , the control group, was just preconditioned. Then the chimerism, hematopoiesis recovery and GVHD were observed. Results: The chimefism of group A,B,C and D were above 80% ,superior to that of control group. All the mice survived except one died of GVHD in group C , while the hematopoiesis recovery of group C was slower than the others. There was no statistic difference between group A and B in GVHD scores(P=0.173 ), however difference existed between group C and D (P=0.033 ). Conclusion :The results indicated that the nonlethal precondition of the mouse model is suitabl; The mice that treated with CD8-DLI showed more severe GVHD than that with whole spleen cell DLI.
出处 《现代肿瘤医学》 CAS 2006年第8期933-936,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(30471944)
关键词 异基因骨髓移植 淋巴细胞输注 移植物抗宿主病 嵌合状态 allogenic-bone marrow transplant donor lymphocytes infusion graft versus host disease chimerism
  • 相关文献

参考文献9

  • 1Nash RA,Storb R.Graft versus host effect after allogeneic hematopoietic stem cell transplantation:GVHD and GVL[J].Curr Opin Immunol,1996,(8):674~680. 被引量:1
  • 2Collins RH Jr,Shpilberg O,Drobyski WR,et al.Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation[J].J Clin Oncol,1997,15 (2):433~444. 被引量:1
  • 3Bryson J S,Jennings CD,Lowery DM,et al.Rejection of an MHC class Ⅱ negative tumor following induction of murine syngeneic graft-versus-host disease[J].Bone Marrow Transplant,1999,23:363~372. 被引量:1
  • 4Champlin R,Khouri I,Kornblau S,et al.Reinventing bone marrow transplantation:reducing toxicity using nonmyeloablative,preparative regimines and induction of graft-versus-malignancy[J].Curr Opin Oncol,1999,11:87~95. 被引量:1
  • 5Kolb HJ,Mittermuller J,Clemm CH,et al.Donor leukocyte transfusions for treatment of recurrenct chronic myelogenous leukemia in marrow trasplant patients[ J].Blood,1990,76:2462~2465. 被引量:1
  • 6Horowitz M M,Gale RP,Sondel P M,et al.Graft versus leukemia reactions after bone marrow transplantation[J].Blood,1990,75(3):555~562. 被引量:1
  • 7Champlin R,Ho W,Gajewski J,et al.Selective depletion of CD8 + T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation[J].Blood,1990,76(2):418~423. 被引量:1
  • 8Nakamura K,Inaba M,Sugiura K,et al.Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion[J].Stem Cells,2004,22(2):125~134. 被引量:1
  • 9Suzuki Y,Adachi Y,Minamino K,et al.A new strategy for treatment of malignant tumor:intra-bone marrow-bone marrow transplantation plus CD4-donor lymphocyte infusion[J].Stem Cells,2005,23(3):365~370. 被引量:1

同被引文献49

  • 1徐文鑫,翁开枝.免疫细胞在白血病免疫治疗应用中的研究进展[J].医学综述,2006,12(12):739-742. 被引量:7
  • 2[1]Lindstein T,June CH,Ledbetter J A,et al.Regulation of lymphokine messenger RNA by a surface mediated T cell activiation pathway.Science,1989,244:339~343. 被引量:1
  • 3[4]SusskindB.HumanImmunol,1996,45:64. 被引量:1
  • 4[6]Ronjon Chakraverty and Megan Sykes.The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.2007,110:9~17. 被引量:1
  • 5[9]BishopMR,TarantoloSR,PavleticZS,et al.Filgrastimasan alternative to donor leukocytein fusion for relapse after allogeneicstem-cell transplantation.ClinOncol,2000,18:2 269~2 272. 被引量:1
  • 6[10]PeggsKS,ThomsonK,HartDP,et al.Dose-escalated donor lymphocyte infusions following reduced intensity transplantation,toxicity,chimerism,and disease responses Blood,2004,103:1 548~1 556. 被引量:1
  • 7[11]Garcia-Manero G,FaderlS,O! Brien S,et al.Chronic Myelogenous Leukemia,A Review and Update of Therapeutic Strategies Cancer,2003,98(3):437~457. 被引量:1
  • 8[12]Alyea E,Weller E,Schlossman R,et al.T-cell depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma,induction of graft-versus-myeloma effect Blood,2001,98:934~939. 被引量:1
  • 9[13]SuzukiY,AdachiY,MinaminoK,et al.A new strategy for treat-mentofmalignant tumor:intra-bonemarrow-bonemarrow trans-2005,23(3):365~370. 被引量:1
  • 10[14]Fabio Ciceri,Chiara Bonini and Sarah Marktel.Anti-tumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation.Blood,2007,6(109):4 698~4 707. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部